Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls
Abstract Background Prior research has established that the prevalence of pathogenic/likely pathogenic (P/LP) variants across all of the American College of Medical Genetics (ACMG) Secondary Findings (SF) genes is approximately 0.8–5%. We investigated the prevalence of P/LP variants in the 24 ACMG S...
Similar Items
-
Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
by: Rajarshi Ghosh, et al.
Published: (2017-11-01) -
High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines
by: Serena Lattante, et al.
Published: (2020-09-01) -
A Case Series of Familial <i>ARID1B</i> Variants Illustrating Variable Expression and Suggestions to Update the ACMG Criteria
by: Pleuntje J. van der Sluijs, et al.
Published: (2021-08-01) -
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
by: Xuewen Xiao, et al.
Published: (2021-06-01) -
Clinical implications and considerations for evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
by: Lora J. H. Bean, et al.
Published: (2017-12-01)